Loading current stock analysis…
Loading current stock analysis…
India
Reported ownership for FY2027-Q2 as of 2026-09-30.
As of 06 Nov 2026, 03:30 pm
Sagility demonstrates a robust operating trajectory with strong earnings quality and improving financial health. In Q2 FY2026-27, revenue from operations rose sequentially to ₹2,032 crore, while expenses decreased slightly to ₹1,671 crore, driving Profit Before Tax up 23% to ₹374 crore. Net profit more than doubled sequentially to ₹284 crore, with EPS increasing to ₹0.61. This operational leverage is supported by a significant deleveraging trend; total borrowings fell from ₹1,402 crore in Mar 2025 to ₹902 crore in Sep 2026, driven by a sharp reduction in non-current debt (₹828 crore to ₹319 crore). Cash generation remains solid, with CFO/EBITDA at 89% for Mar 2026 and cash reserves growing to ₹532 crore as of Sep 2026. Return on Capital Employed (ROCE) has improved materially to 13% in Mar 2026. However, the Cash Conversion Cycle lengthened to 93 days in Mar 2026, suggesting a need to monitor working capital efficiency. Shareholding shows promoter stakes stabilizing at 50.95% in Sep 2026 after a dip from 67.38% in Sep 2025, while DII and FII holdings increased.
Key Points: - **Strong Sequential Earnings Growth**: Q2 FY2026-27 net profit surged to ₹284 crore (+31% YoY, +31% sequential), with EPS rising to ₹0.61, reflecting effective cost control as expenses fell despite revenue growth. - **Deleveraging Trend**: Total borrowings declined consistently to ₹902 crore (Sep 2026) from ₹1,402 crore (Mar 2025), with non-current debt dropping significantly to ₹319 crore, strengthening the balance sheet. - **Improving Returns & Liquidity**: ROCE improved to 13% (Mar 2026) and cash reserves nearly doubled to ₹532 crore (Sep 2026), indicating better capital allocation and liquidity position. - **Working Capital Monitor**: The Cash Conversion Cycle extended to 93 days (Mar 2026) from 83 days (Mar 2025); investors should watch if this trend persists in subsequent quarters.
Sagility declared an interim dividend of ₹0.15 per share. The record date for this payout is 30 October 2026. Investors holding equity shares on this date are eligible to receive the dividend.
As of 6 November 2026, Sagility’s shares closed at ₹43.46. Over the trailing one-year period, the stock returned -14.2%, while it has declined -16.5% year-to-date. The stock is currently trading near recent support levels around ₹43.38.
Technical indicators as of 6 November 2026 show a bearish trend across daily, weekly, and monthly timeframes. The Supertrend direction is bearish, and the Average Directional Index (ADX) is low (12.23 on daily), suggesting weak trend strength despite the downward bias.
Sagility uploaded transcripts from an investor meet held on 22 October 2026 to its website on 28 October 2026. However, the exchange filing confirms that the transcript contents are not provided in the public announcement, limiting immediate access to management insights.
As of 06 Nov 2026, 03:30 pm
Showing 3 of 6 candles
Recent drawdown or price variability is high enough to warrant closer monitoring.
Primary driver: Price remains materially below a previous peak
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
The session opened materially below the previous close, indicating a sharp repricing at the open.
The price gap may increase short-term downside uncertainty and warrants review of the underlying context.
Trading activity was substantially higher than usual and the price closed lower.
This may reflect stronger-than-usual market participation; follow-through and relevant company or market news merit review.
Latest complete financial results for Q2 FY27 and comparative quarterly trends.
| Metric | Q2 FY26 | Q1 FY27 | Q2 FY27(Latest) |
|---|---|---|---|
| Revenue From Operations | ₹1,658 crore | ₹1,963 crore | PEAK₹2,032 crore |
| Expenses | ₹1,390 crore | PEAK₹1,675 crore | ₹1,671 crore |
| Profit Before Exceptional Items And Tax | ₹327 crore | ₹303 crore | PEAK₹374 crore |
| Profit Loss For Period | ₹251 crore | ₹217 crore | PEAK₹284 crore |
| Basic Earnings Loss Per Share From Continuing And Discontinued Operations | ₹0.53 per share | ₹0.46 per share | PEAK₹0.61 per share |
Sagility’s consolidated revenue from operations rose 3.5% quarter on quarter to ₹2,032 crore in Q2 FY2026-27, while profit for the period increased 31.1% to ₹284 crore. Year on year, revenue grew 22.5% and profit rose 13.3%; total expenses were marginally lower than in Q1, and finance costs declined.
Sagility paired 3.5% sequential revenue growth with a 31.1% increase in profit for Q2 FY2026-27. Cash and current investments were higher and borrowings lower than at 31 March 2026, alongside a decline in finance costs.
Disclosed bulk and block transactions involving Sagility, shown for the latest 90 days.
Exchange disclosures and regulatory announcements for Sagility.
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
Sagility Limited uploaded the transcript of its earnings or quarterly call held on 22 October 2026 to its website on 28 October 2026 and informed the Exchange on 29 October 2026. The filing records the call’s conclusion time as 20:30 and the transcript upload time as 23:11; it does not provide the transcript’s substantive contents.
SAGILITY LIMITED has informed the Exchange about Transcript |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
SERIES:EQ |PURPOSE:INTERIM DIVIDEND - RE 0.15 PER SHARE |FACE VALUE:10 |RECORD DATE:30-Oct-2026 |BOOK CLOSURE START DATE:- |BOOK CLOSURE END DATE:-
Recent market and company developments associated with Sagility.
A promoter of Sagility sold a 12% stake for Rs 2,395 crore. Smallcap World Fund raised its holding in Lotus Developers.
IIFL Capital launched a block deal for up to 56 crore shares of Sagility Ltd, potentially worth nearly Rs 2,400 crore ($250 million), with Netherlands-based Sagility BV acting as the seller. This transaction represents a reduction in stake by the promoter group entity in the Indian listed arm.
Several listed entities reported specific corporate developments: NIIT Learning completed a $17.6 million acquisition of Bluewater, Sagility is preparing a 12% stake sale, IDBI Bank continues its disinvestment round, NBCC achieved a marquee sale at rising prices, and OnMobile expanded its distribution with Savex.
NIIT Learning Systems Ltd completed the acquisition of 100% stake in Bluewater Learning, LLC for up to $17.6 million, while Reliance Industries and Jio Platforms released their key financial results for the period.
Trent reported a 25.3% YoY increase in consolidated profit to Rs 468.09 crore for Q2FY27, with revenue climbing 22%. Lodha Developers is among the companies scheduled to release their second-quarter earnings results on October 30.
Promoter Sagility B.V. plans to offload a 12% stake in healthcare services provider Sagility via a block deal at ₹42.45 per share, representing a 5% discount and totaling approximately ₹2,377 crore. This sale follows a gradual reduction in the promoter's holding from 67.38% a year ago to 50.95% as of the September quarter-end.
Promoter Sagility B.V. is reportedly planning to sell a 12% stake in healthcare IT services provider Sagility via a block deal valued at Rs 2,377 crore. The transaction implies a floor price of Rs 42.45 per share, representing a discount of up to 4.9% to the previous closing price, with a 365-day lock-up on the residual stake.
Netherlands-based parent company Sagility BV is proposing to offload a 12% stake in healthcare services provider Sagility via a block deal valued at approximately ₹2,377 crore, with a floor price of ₹42.45 per share. This transaction follows a period of significant promoter selling and institutional buying activity over the past year, during which Sagility's stock has declined by more than 14% in 2026.
Comprehensive Section Breakdown for Sagility
Strategic Vision: Transformation partner for healthcare operations using technology.
Category: B2B Services
Sagility provides business process management services employing AI, intelligent automation, and deep domain expertise to assist clients in reducing administrative costs, automating workflows, and optimizing performance.
Key Products & Services: CareSeed • SmarTec Nurse Assist
• Integration of AI, intelligent automation, and deep domain expertise in healthcare operations.
• Focus on simplifying healthcare processes and enhancing operational performance for payers and providers.
Revenue from operations increased by ₹69 crore from ₹1,963 crore in Q1 FY2026-27. Compared with Q2 FY2025-26, revenue was up from ₹1,659 crore. Total expenses edged down 0.3% sequentially to ₹1,671 crore from ₹1,675 crore. Employee benefit expense was ₹1,229 crore and depreciation, depletion and amortisation expense was ₹132 crore. Other expenses fell 2.5% quarter on quarter to ₹290 crore.
The combination of higher revenue and slightly lower expenses accompanied stronger quarterly profit.
Profit before tax rose 30.2% quarter on quarter to ₹374 crore from ₹287 crore, and was 14.5% higher than the ₹327 crore recorded in Q2 FY2025-26. Profit before exceptional items and tax was also ₹374 crore, compared with ₹303 crore in Q1 FY2026-27. Profit for the period increased to ₹284 crore from ₹217 crore in Q1 and ₹251 crore a year earlier. Tax expense rose 27.4% sequentially to ₹90 crore.
Basic and diluted EPS from continuing operations were both ₹0.61, up from ₹0.46 in Q1. Comprehensive income increased to ₹347 crore from ₹261 crore in the preceding quarter; other comprehensive income was ₹63 crore.
Finance costs declined 15.3% quarter on quarter to ₹18.5 crore from ₹21.9 crore. At 30 September 2026, cash and cash equivalents stood at ₹532 crore, compared with ₹358 crore at 31 March 2026; current investments were ₹399 crore, up from ₹336 crore.
Total assets increased to ₹12,858 crore from ₹12,601 crore over the same dates. Goodwill rose to ₹6,609 crore from ₹6,405 crore, while current trade receivables declined to ₹1,775 crore from ₹1,839 crore. Equity attributable to owners of the parent increased to ₹10,228 crore from ₹9,659 crore.
Current and non-current borrowings totalled ₹902 crore at 30 September 2026, down from ₹1,111 crore at 31 March 2026. The lower borrowing balance coincided with lower quarterly finance costs.
Core Thesis: The business units reinforce each other by combining advanced technology with deep-domain expertise to deliver tailored solutions and act as a transformation partner.
• Intelligent Technologies: Leveraging AI and intelligent automation to simplify healthcare processes and enhance operational performance. • Human-Centered Operations: Employing human expertise alongside technology to deliver tailored solutions for healthcare payers and providers. • Domain Expertise: Utilizing deep knowledge of healthcare operations to assist clients in improving specific performance metrics and driving revenue.